Effect of YM087, a Potent Nonpeptide Vasopressin Antagonist, on Vasopressin-Induced Hyperplasia and Hypertrophy of Cultured Vascular Smooth-Muscle Cells-Reference-Cited by-同舟云学术

Effect of YM087, a Potent Nonpeptide Vasopressin Antagonist, on Vasopressin-Induced Hyperplasia and Hypertrophy of Cultured Vascular Smooth-Muscle Cells

Published:1997-12 Issue:6 Volume:30 Page:759-766
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Tahara Atsuo,Tomura Yuichi,Wada Koh-ichi,Kusayama Toshiyuki,Tsukada Junko,Ishii Noe,Yatsu Takeyuki,Uchida Wataru,Tanaka Akihiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference31 articles.

1. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.

2. Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets

3. AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posterior Pituitary Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Posterior Pituitary Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2015

3. A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model;European Journal of Obstetrics & Gynecology and Reproductive Biology;2014-03

4. Diuretic Use in Heart Failure and Outcomes;Clinical Pharmacology & Therapeutics;2013-07-12

5. Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents;Drug Discovery Today;2010-10